Intrinsic Value of S&P & Nasdaq Contact Us

Pro-Dex, Inc. PDEX NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$33.22
-37%

Pro-Dex, Inc. (PDEX) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $0.50 and revenue of $0.05B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.61 vs est $0.50 (beat +22%). 2025: actual $2.73 vs est $2.81 (missed -2.8%). Analyst accuracy: 90%.

PDEX Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to Pro-Dex, Inc. in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — PDEX

90%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.61 vs Est $0.50 ▲ 18.0% off
2025 Actual $2.73 vs Est $2.81 ▼ 2.9% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.

Revenue Estimates — PDEX

95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.054B vs Est $0.049B ▲ 9.0% off
2025 Actual $0.067B vs Est $0.067B ▼ 0.6% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message